DBT: BOD resolution dated June 28, 2022

The Board resolution dated June 28, 2022, the BOD of BenTre Pharmaceutical Joint Stock Company approved the following comtents:

1. Approved the plan for stock issuance under ESOP and stock dividend payment.
2. Approved the adjustment of DBT’s organization chart.
3. Approved the selection of Ernst & Young Vietnam Company Limited as the auditor for the financial statements in 2022.
4. Approved the purchase of shares to increase the ownership ratio of DBT in Yen Bai Joint-stocks Pharmaceutical Company.

HOSE

>   HNG: Selection of audit firm (01/07/2022)

>   HII: Buying shares of An Thanh Bicsol (01/07/2022)

>   LPB: SSC approved the result of public offering (01/07/2022)

>   MCG: Transferring shares in subsidiary (01/07/2022)

>   PJT: Signing audit contract (01/07/2022)

>   PJT: Approved the Internal Audit Regulation (01/07/2022)

>   CMV: Signing an audit contract (01/07/2022)

>   QBS: Completing the transfer of shares in ICD Quang Binh – Dinh Vu (01/07/2022)

>   CLW: Signing an audit contract (01/07/2022)

>   NHA: Signing an audit contract (01/07/2022)